<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15-molecules-24-01552">
 <label>15.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>C.C.</given-names>
   </name>
   <name>
    <surname>Hsu</surname>
    <given-names>W.C.</given-names>
   </name>
   <name>
    <surname>Chung</surname>
    <given-names>C.Y.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>C.C.</given-names>
   </name>
   <name>
    <surname>Jassey</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>S.P.</given-names>
   </name>
   <name>
    <surname>Tai</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Tai</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Shields</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Highly bioavailable silibinin nanoparticles inhibit HCV infection</article-title>
  <source>Gut</source>
  <year>2017</year>
  <volume>66</volume>
  <fpage>1853</fpage>
  <lpage>1861</lpage>
  <pub-id pub-id-type="doi">10.1136/gutjnl-2016-312019</pub-id>
  <pub-id pub-id-type="pmid">27436270</pub-id>
 </element-citation>
</ref>
